Article
Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study.
Pharmacogenetics and genomics - 1 May 2012
Lynch Amy I, Eckfeldt John H, Davis Barry R, Ford Charles E, Boerwinkle Eric, Leiendecker-Foster Catherine, Arnett Donna K
Abstract excerpt
OBJECTIVE: To identify panels of genetic variants that predict treatment-related coronary heart disease (CHD) outcomes in hypertensive patients on one of four different classes of initial antihypertensive treatment. The goal was to identify subgroups of individuals on the basis of their genetic profile who benefit most from a particular treatment. METHODS: Candidate genetic variants (n=78) were genotyped in 39...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
